ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Treating Opioid Use Disorder in General Practice — Diagnosis, Harm Reduction, and Medications | NEJM

Автор: NEJM Group

Загружено: 2024-01-11

Просмотров: 7113

Описание: In this Double Take video from the New England Journal of Medicine and NEJM
Group, L.J. Punch (the T St. Louis, a harm-reduction program), Sarah
Bagley (Boston Medical Center), Jennifer Foreman (Randolph Health Medical
Group), and Scott Hadland (Massachusetts General Hospital for Children) review
how primary care providers can best care for patients with opioid use disorder.
They guide clinicians on how to diagnose the disorder, build trust with patients,
offer counseling on harm reduction, and use medications to treat addiction and
withdrawal symptoms. They also emphasize the importance of reducing stigma
to improve therapeutic alliances with this patient population.

To learn more about the latest practices for assessing and managing acute
and chronic pain, current guidelines for the appropriate use of opioids for pain
management, and evidence-based strategies for recognizing and treating opioid
use disorder, participate in a free NEJM Group Pain Management and
Opioids program, available at https://cme-info.nejm.org/oud-double-... .

For further reading on stigma reduction, review the following articles: Stigma
Reduction to Combat the Addiction Crisis — Developing an Evidence Base
(McGinty and Barry, in the April 2, 2020, issue; https://www.nejm.org/doi/full/10.1056... ), and Stigma as a Fundamental
Hindrance to the United States Opioid Overdose Crisis Response (Tsai et al., in
the November 26, 2019, issue of PLOS Medicine; https://journals.plos.org/plosmedicin... ).

For further reading on alternative dosing of buprenorphine and naloxone,
review the following articles: Low-Dose Initiation of Buprenorphine in
Hospitalized Patients on Full Agonist Opioid Therapy: A Retrospective
Observational Study (Schult et al, in the November 12, 2023, issue of the Journal
of Addiction Medicine; https://journals.lww.com/journaladdic... ), and Microinduction of Buprenorphine/Naloxone:
A Review
of the Literature (Ahmed et al., in the December 30, 2020, issue of the American
Journal on Addictions; https://onlinelibrary.wiley.com/doi/1... ).



The New England Journal of Medicine is the world’s leading general medical journal. Continuously published for over 200 years, the Journal publishes
peer-reviewed research along with interactive clinical content for physicians,
educators, and the global medical community at https://NEJM.org.

#opioidcrisis #opioids #addiction #substanceusedisorder #painmanagement

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Treating Opioid Use Disorder in General Practice — Diagnosis, Harm Reduction, and Medications | NEJM

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Buprenorphine - Prescribing Basics | Palliative Care Grand Rounds

Buprenorphine - Prescribing Basics | Palliative Care Grand Rounds

Alzheimer’s Disease — Managing Stages of Dementia | NEJM

Alzheimer’s Disease — Managing Stages of Dementia | NEJM

Harm Reduction, Overdose Prevention and Naloxone Training: A Webinar | Grey Bruce Public Health

Harm Reduction, Overdose Prevention and Naloxone Training: A Webinar | Grey Bruce Public Health

What Is Rheumatoid Arthritis? | NEJM

What Is Rheumatoid Arthritis? | NEJM

4 Hours Chopin for Studying, Concentration & Relaxation

4 Hours Chopin for Studying, Concentration & Relaxation

Opioid Use Disorder Treatment: New Challenges and Opportunities

Opioid Use Disorder Treatment: New Challenges and Opportunities

Sickle Cell Disease and Gene Therapy — Patient and Physician Perspectives | NEJM

Sickle Cell Disease and Gene Therapy — Patient and Physician Perspectives | NEJM

#005 Who is the right PATIENT for opioid tapering?

#005 Who is the right PATIENT for opioid tapering?

My Stage IV Kidney Cancer Diagnosis Story

My Stage IV Kidney Cancer Diagnosis Story

Синдром Гийена-Барре: от ранних симптомов до диагностики и лечения | История Холли о синдроме Гий...

Синдром Гийена-Барре: от ранних симптомов до диагностики и лечения | История Холли о синдроме Гий...

Overview of Heat-Related Illnesses | NEJM

Overview of Heat-Related Illnesses | NEJM

Бупренорфин/Субоксон: все, что вам нужно знать!

Бупренорфин/Субоксон: все, что вам нужно знать!

Рак почки IV стадии: путь к операции. Часть 1

Рак почки IV стадии: путь к операции. Часть 1

The Pressures Of Being A Veterinarian In Our World Today | Beyond Sheltering | Free Documentary

The Pressures Of Being A Veterinarian In Our World Today | Beyond Sheltering | Free Documentary

Smartphones: It’s Time to Confront Our Global Addiction | Dr. Justin Romano | TEDxOmaha

Smartphones: It’s Time to Confront Our Global Addiction | Dr. Justin Romano | TEDxOmaha

Pharmacology Analgesics - Opioids, NSAIDS, Tylenol - Nursing RN PN (MADE EASY)

Pharmacology Analgesics - Opioids, NSAIDS, Tylenol - Nursing RN PN (MADE EASY)

Opioid Addiction and its Treatment, Dr. Belis Aladag | UCLAMDChat

Opioid Addiction and its Treatment, Dr. Belis Aladag | UCLAMDChat

Tickborne Diseases | NEJM

Tickborne Diseases | NEJM

Налоксон – антагонист опиоидных рецепторов | Медсестринская фармакология

Налоксон – антагонист опиоидных рецепторов | Медсестринская фармакология

Varenicline and cytisine; an overview - Professor Sanjay Agrawal & Professor Matthew Evison

Varenicline and cytisine; an overview - Professor Sanjay Agrawal & Professor Matthew Evison

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]